Marimed (MRMD) Total Liabilities (2011 - 2026)
Marimed (MRMD) posted quarterly Total Liabilities of $147.7 million for Q1 2026, up 10.2% year-over-year from $134.1 million in Q1 2025, and up 7.19% quarter-over-quarter from $137.8 million in Q4 2025.
Marimed (MRMD) Total Liabilities (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Total Liabilities for 16 consecutive years, with $147.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 10.2% year-over-year to $147.7 million; the TTM figure through Mar 2026 stood at $147.7 million (up 10.2% YoY), while the FY2025 annual figure was $137.8 million, up 6.48% from the prior year.
- Total Liabilities advanced to $147.7 million in Q1 2026 per MRMD's latest filing, from $137.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $147.7 million in Q1 2026 and bottomed at $50.7 million in Q2 2022.
- Historically, Total Liabilities has averaged $103.7 million across 5 years, with a median of $113.5 million in 2024.
- Annual changes were most pronounced in 2023 — Total Liabilities surged 87.54% — and 2025, when it advanced 6.48%.
- Marimed's Total Liabilities stood at $57.2 million in 2022, then surged by 87.54% to $107.2 million in 2023, then advanced by 20.74% to $129.4 million in 2024, then grew by 6.48% to $137.8 million in 2025, then gained by 7.19% to $147.7 million in 2026.
- Business Quant data shows MRMD's Total Liabilities at $147.7 million in Q1 2026, $137.8 million in Q4 2025, and $136.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 147.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 147.06 Mn |
| Mar 31, 2026 | 147.74 Mn |
| Dec 31, 2025 | 137.83 Mn |
| Sep 30, 2025 | 136.55 Mn |
| Jun 30, 2025 | 131.20 Mn |
| Mar 31, 2025 | 134.06 Mn |
| Dec 31, 2024 | 129.44 Mn |
| Sep 30, 2024 | 125.84 Mn |
| Jun 30, 2024 | 120.93 Mn |
| Mar 31, 2024 | 113.51 Mn |
| Dec 31, 2023 | 107.21 Mn |
| Sep 30, 2023 | 91.96 Mn |
| Jun 30, 2023 | 86.56 Mn |
| Mar 31, 2023 | 81.40 Mn |
| Dec 31, 2022 | 57.17 Mn |
| Sep 30, 2022 | 55.10 Mn |
| Jun 30, 2022 | 50.70 Mn |
| Mar 31, 2022 | 55.67 Mn |
| Dec 31, 2021 | 49.18 Mn |
| Sep 30, 2021 | 45.21 Mn |